Vaccination

Germany seeks ways to give its vaccine campaign momentum

Chancellor Angela Merkel and German state governors were planning to talk Monday with representatives of the pharmaceutical industry on ways to beef up the country's sluggish vaccination campaign.

Vaccination

BioNTech-Pfizer pledges up to 75 mn more jabs to EU

BioNTech and Pfizer said Monday they will ramp up their coronavirus vaccine deliveries to the European Union, pledging to send up to 75 million extra doses to the bloc in the spring.

Vaccination

Denmark slows vaccine rollout after Pfizer delivery delays

Denmark announced Wednesday that it was revising its targets for COVID-19 vaccinations down by 10 percent in the first quarter due the temporary reduction in deliveries of the Pfizer/BioNTech vaccine in Europe.

Diseases, Conditions, Syndromes

Peru surpasses 200,000 coronavirus infections: health ministry

Peru emerged as a global COVID-19 hotspot on Tuesday as the health ministry registered more than 200,000 cases, ranking the South American country as the eighth-highest in the world by number of infections.

Other

Novartis profit up as world flocks to buy medecine

Swiss pharma giant Novartis on Tuesday reported higher profits for the first quarter as customers rushing to buy treatments during the coronavirus outbreak boosted the bottom line.

Medications

Lundbeck profit jumps but warns on generic pressure

Danish pharmaceutical company Lundbeck Wednesday posted a higher than expected quarterly net profit, helped by the expansion of an alliance with Japan's Otsuka and the divestment of a US portfolio of non-core products.

Medications

Bayer profits up 11.5 percent on new drugs

German chemical and pharmaceutical company Bayer AG said Thursday that its net profit rose 11.5 percent in the first quarter as new drugs, led by blood thinner Xarelto, boosted sales.

page 3 from 4